North America Human Microbiome Market Size, Share & Industry Trends Analysis Report By Product, By Disease Type, By Technology, By Application, By Type, By Country and Growth Forecast, 2022

List of Tables

The North America Human Microbiome Market would witness market growth of 31.4% CAGR during the forecast period (2022-2028).

The intestinal microbiota contributes significantly to the nutritional needs of its host. Complex dietary elements that are indigestible (complex carbohydrates) are aggressively broken down by these organisms, making complex food ingredients readily available for digestion and absorption and hence, play a crucial role in maintaining the health of the host. These factors are propelling the demand for synthetic human microbiome and therefore, the growth of the human microbiome market is being augmented.

Many microbes invade humans, with non-human cells of nearly the same order of magnitude as human cells. Some bacteria that colonize people are commensal, indicating they coexist with humans without harming them, whereas others have a mutualistic connection with them. Non-pathogenic bacteria, on the other hand, can cause harm to human hosts by the metabolites they create, such as trimethylamine, which the human body transforms to trimethylamine N-oxide through FMO3-mediated oxidation. Certain microbes carry out actions that are known to benefit the human host, but the majority of their functions are unidentified. Those that are estimated to be present and do not cause disease in typical circumstances are referred to as normal flora or normal microbiota.

There is a robust prevalence of obesity in the United States. According to the Harvard TH Chan's School of Public Health, obesity prevalence in the United States was 41.9% from 2017 to 2020. Obesity prevalence in the United States climbed from 30.5% to 41.9% between 1999 and 2020. The prevalence of severe obesity grew from 4.7% to 9.2% throughout this time. Heart disease, type 2 diabetes, stroke, along with some types of cancer are all linked to obesity. These are some of the most common causes of preventable death. In 2019, the estimated yearly medical cost of obesity in the United States was about $173 billion. Adults with obesity had medical costs that were $1,861 more than those with a healthy weight. The highest age-adjusted prevalence of obesity was seen among non-Hispanic Black adults (49.9%), preceded by Hispanic adults (45.6%), non-Hispanic White adults (41.4%), and non-Hispanic Asian adults (16.1%). Obesity was shown to be prevalent in adults aged 20 to 39 years, 44.3% in adults aged between 40 to 59 years, and 41.5% in people aged 60 and above.

The US market dominated the North America Human Microbiome Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $307.7 million by 2028. The Canada market is experiencing a CAGR of 34.4% during (2022 - 2028). Additionally, The Mexico market would exhibit a CAGR of 33.2% during (2022 - 2028).

Based on Product, the market is segmented into Drugs, Diagnostic Tests, Probiotics, Prebiotics, and Others. Based on Disease Type, the market is segmented into Infectious Diseases, Endocrine & Metabolic Disorders, Gastrointestinal Diseases, Cancer, and Others. Based on Technology, the market is segmented into Genomics, Proteomics and Metabolomics. Based on Application, the market is segmented into Therapeutics and Diagnostics. Based on Type, the market is segmented into Microbiome Consortia Transplantation (FMT), Peptide, Live Biotherapeutic Product and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Seres Therapeutics, Inc., 4D pharma plc, OptiBiotix Health Plc, Synlogic, Inc., Second Genome, Inc., Vedanta Biosciences, Inc., Finch Therapeutics Group, Inc., Ferring Holdings SA, and Enterome.

Scope of the Study

Market Segments covered in the Report:

By Product

Drugs
Diagnostic Tests
Probiotics
Prebiotics, and
Others

By Disease Type

Infectious Diseases
Endocrine & Metabolic Disorders
Gastrointestinal Diseases
Cancer, and
Others

By Technology

Genomics
Proteomics
Metabolomics

By Application

Therapeutics
Diagnostics

By Type

Microbiome Consortia Transplantation (FMT)
Peptide
Live Biotherapeutic Product
Others

By Country

US
Canada
Mexico
Rest of North America

Companies Profiled

Seres Therapeutics, Inc.
4D pharma plc
OptiBiotix Health Plc
Synlogic, Inc.
Second Genome, Inc.
Vedanta Biosciences, Inc.
Finch Therapeutics Group, Inc.
Ferring Holdings SA
Enterome

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 North America Human Microbiome Market, by Product
- 1.4.2 North America Human Microbiome Market, by Disease Type
- 1.4.3 North America Human Microbiome Market, by Technology
- 1.4.4 North America Human Microbiome Market, by Application
- 1.4.5 North America Human Microbiome Market, by Type
- 1.4.6 North America Human Microbiome Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction
- 2.1.1 Overview
  - 2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints

Chapter 3. North America Human Microbiome Market by Product

3.1 North America Drugs Market by Country
3.2 North America Diagnostic Tests Market by Country
3.3 North America Probiotics Market by Country
3.4 North America Prebiotics Market by Country
3.5 North America Others Market by Country

Chapter 4. North America Human Microbiome Market by Disease Type

4.1 North America Infectious Diseases Market by Country
4.2 North America Endocrine & Metabolic Disorders Market by Country
4.3 North America Gastrointestinal Diseases Market by Country
4.4 North America Cancer Market by Country
4.5 North America Others Market by Country

Chapter 5. North America Human Microbiome Market by Technology

5.1 North America Genomics Market by Country
5.2 North America Proteomics Market by Country
5.3 North America Metabolomics Market by Country

Chapter 6. North America Human Microbiome Market by Application

6.1 North America Therapeutics Market by Country
6.2 North America Diagnostics Market by Country

Chapter 7. North America Human Microbiome Market by Type

7.1 North America Microbiome Consortia Transplantation (FMT) Market by Country
7.2 North America Peptide Market by Country
7.3 North America Live Biotherapeutic Product Market by Country
7.4 North America Others Market by Country

Chapter 8. North America Human Microbiome Market by Country

8.1 US Human Microbiome Market
- 8.1.1 US Human Microbiome Market by Product
- 8.1.2 US Human Microbiome Market by Disease Type
- 8.1.3 US Human Microbiome Market by Technology
- 8.1.4 US Human Microbiome Market by Application
- 8.1.5 US Human Microbiome Market by Type
8.2 Canada Human Microbiome Market
- 8.2.1 Canada Human Microbiome Market by Product
- 8.2.2 Canada Human Microbiome Market by Disease Type
- 8.2.3 Canada Human Microbiome Market by Technology
- 8.2.4 Canada Human Microbiome Market by Application
- 8.2.5 Canada Human Microbiome Market by Type
8.3 Mexico Human Microbiome Market
- 8.3.1 Mexico Human Microbiome Market by Product
- 8.3.2 Mexico Human Microbiome Market by Disease Type
- 8.3.3 Mexico Human Microbiome Market by Technology
- 8.3.4 Mexico Human Microbiome Market by Application
- 8.3.5 Mexico Human Microbiome Market by Type
8.4 Rest of North America Human Microbiome Market
- 8.4.1 Rest of North America Human Microbiome Market by Product
- 8.4.2 Rest of North America Human Microbiome Market by Disease Type
- 8.4.3 Rest of North America Human Microbiome Market by Technology
- 8.4.4 Rest of North America Human Microbiome Market by Application
- 8.4.5 Rest of North America Human Microbiome Market by Type

Chapter 9. Company Profiles

9.1 Ferring Holdings SA
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Regional Analysis
- 9.1.4 Research and Development Expense
- 9.1.5 Recent Strategies and Developments:
  - 9.1.5.1 Partnerships, Collaborations, and Agreements:
9.2 Enterome
- 9.2.1 Company Overview
- 9.2.2 Recent Strategies and Developments:
  - 9.2.2.1 Partnerships, Collaborations, and Agreements:
9.3 Seres Therapeutics, Inc.
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Research & Development Expense
- 9.3.4 Recent Strategies and Developments:
  - 9.3.4.1 Partnerships, Collaborations, and Agreements:
9.4 4D Pharma Plc
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Research & Development Expense
- 9.4.4 Recent Strategies and Developments:
  - 9.4.4.1 Partnerships, Collaborations, and Agreements:
9.5 OptiBiotix Health Plc
- 9.5.1 Company Overview
9.6 Synlogic, Inc.
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Research & Development Expense
9.7 Second Genome, Inc.
- 9.7.1 Company Overview
9.8 Vedanta Biosciences, Inc.
- 9.8.1 Company Overview
9.9 Finch Therapeutics Group, Inc.
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Research & Development Expense

LIST OF TABLES

TABLE 1 North America Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 2 North America Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 3 North America Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 4 North America Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 5 North America Drugs Market by Country, 2018 - 2021, USD Thousands
TABLE 6 North America Drugs Market by Country, 2022 - 2028, USD Thousands
TABLE 7 North America Diagnostic Tests Market by Country, 2018 - 2021, USD Thousands
TABLE 8 North America Diagnostic Tests Market by Country, 2022 - 2028, USD Thousands
TABLE 9 North America Probiotics Market by Country, 2018 - 2021, USD Thousands
TABLE 10 North America Probiotics Market by Country, 2022 - 2028, USD Thousands
TABLE 11 North America Prebiotics Market by Country, 2018 - 2021, USD Thousands
TABLE 12 North America Prebiotics Market by Country, 2022 - 2028, USD Thousands
TABLE 13 North America Others Market by Country, 2018 - 2021, USD Thousands
TABLE 14 North America Others Market by Country, 2022 - 2028, USD Thousands
TABLE 15 North America Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 16 North America Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 17 North America Infectious Diseases Market by Country, 2018 - 2021, USD Thousands
TABLE 18 North America Infectious Diseases Market by Country, 2022 - 2028, USD Thousands
TABLE 19 North America Endocrine & Metabolic Disorders Market by Country, 2018 - 2021, USD Thousands
TABLE 20 North America Endocrine & Metabolic Disorders Market by Country, 2022 - 2028, USD Thousands
TABLE 21 North America Gastrointestinal Diseases Market by Country, 2018 - 2021, USD Thousands
TABLE 22 North America Gastrointestinal Diseases Market by Country, 2022 - 2028, USD Thousands
TABLE 23 North America Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 24 North America Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 25 North America Others Market by Country, 2018 - 2021, USD Thousands
TABLE 26 North America Others Market by Country, 2022 - 2028, USD Thousands
TABLE 27 North America Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 28 North America Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 29 North America Genomics Market by Country, 2018 - 2021, USD Thousands
TABLE 30 North America Genomics Market by Country, 2022 - 2028, USD Thousands
TABLE 31 North America Proteomics Market by Country, 2018 - 2021, USD Thousands
TABLE 32 North America Proteomics Market by Country, 2022 - 2028, USD Thousands
TABLE 33 North America Metabolomics Market by Country, 2018 - 2021, USD Thousands
TABLE 34 North America Metabolomics Market by Country, 2022 - 2028, USD Thousands
TABLE 35 North America Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 36 North America Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 37 North America Therapeutics Market by Country, 2018 - 2021, USD Thousands
TABLE 38 North America Therapeutics Market by Country, 2022 - 2028, USD Thousands
TABLE 39 North America Diagnostics Market by Country, 2018 - 2021, USD Thousands
TABLE 40 North America Diagnostics Market by Country, 2022 - 2028, USD Thousands
TABLE 41 North America Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 42 North America Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 43 North America Microbiome Consortia Transplantation (FMT) Market by Country, 2018 - 2021, USD Thousands
TABLE 44 North America Microbiome Consortia Transplantation (FMT) Market by Country, 2022 - 2028, USD Thousands
TABLE 45 North America Peptide Market by Country, 2018 - 2021, USD Thousands
TABLE 46 North America Peptide Market by Country, 2022 - 2028, USD Thousands
TABLE 47 North America Live Biotherapeutic Product Market by Country, 2018 - 2021, USD Thousands
TABLE 48 North America Live Biotherapeutic Product Market by Country, 2022 - 2028, USD Thousands
TABLE 49 North America Others Market by Country, 2018 - 2021, USD Thousands
TABLE 50 North America Others Market by Country, 2022 - 2028, USD Thousands
TABLE 51 North America Human Microbiome Market by Country, 2018 - 2021, USD Thousands
TABLE 52 North America Human Microbiome Market by Country, 2022 - 2028, USD Thousands
TABLE 53 US Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 54 US Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 55 US Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 56 US Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 57 US Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 58 US Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 59 US Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 60 US Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 61 US Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 62 US Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 63 US Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 64 US Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 65 Canada Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 66 Canada Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 67 Canada Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 68 Canada Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 69 Canada Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 70 Canada Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 71 Canada Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 72 Canada Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 73 Canada Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 74 Canada Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 75 Canada Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 76 Canada Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 77 Mexico Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 78 Mexico Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 79 Mexico Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 80 Mexico Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 81 Mexico Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 82 Mexico Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 83 Mexico Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 84 Mexico Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 85 Mexico Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 86 Mexico Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 87 Mexico Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 88 Mexico Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 89 Rest of North America Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 90 Rest of North America Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 91 Rest of North America Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 92 Rest of North America Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 93 Rest of North America Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 94 Rest of North America Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 95 Rest of North America Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 96 Rest of North America Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 97 Rest of North America Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 98 Rest of North America Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 99 Rest of North America Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 100 Rest of North America Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 101 key information - Ferring Holdings SA
TABLE 102 Key information - Enterome
TABLE 103 KEY INFORMATION - Seres Therapeutics, Inc.
TABLE 104 Key Information - 4D pharma plc
TABLE 105 key Information - OptiBiotix Health Plc
TABLE 106 Key Information - Synlogic, Inc.
TABLE 107 Key Information - Second Genome, Inc.
TABLE 108 Key Information - Vedanta Biosciences, Inc.
TABLE 109 key information - Finch Therapeutics Group, Inc.

List of Figures

FIG 1 Methodology for the research

North America Human Microbiome Market Size, Share & Industry Trends Analysis Report By Product, By Disease Type, By Technology, By Application, By Type, By Country and Growth Forecast, 2022 - 2028

Description

Table of Contents